Maynard O’Connor prevails in a medical malpractice appeal. In that case, the plaintiff claimed injuries stemming from the defendants’ alleged failure to administer tissue plasminogen activator (tPA) therapy for treatment of a stroke. On their motion for summary judgment, the defendants established prima facie evidence that they did not commit malpractice, and that tPA therapy was contraindicated in the plaintiff’s care. The plaintiff then sought appellate review arguing that the lower court failed to consider their expert’s opinion that the defendants committed malpractice. Rob Rausch argued the appeal on behalf of the defendants. The Third Department Appellate Division unanimously affirmed the lower court’s decision in holding that the defendants did not commit malpractice, and that tPA therapy was contraindicated.